Airsculpt Technologies, Inc. Earnings Per Share Disclosure
| Fiscal Year Ended December 31, | |||||||||||
| 2025 | 2024 | 2023 | |||||||||
| Numerator: | |||||||||||
| Net loss | $ | (11,667) | $ | (8,018) | $ | (4,240) | |||||
| Denominator: | |||||||||||
| Weighted average shares of common stock outstanding - basic | 60,450,769 | 57,688,906 | 56,778,793 | ||||||||
| Add: Effect of dilutive securities | — | — | — | ||||||||
| Weighted average shares of common stock outstanding - diluted | 60,450,769 | 57,688,906 | 56,778,793 | ||||||||
| Loss per share of common stock outstanding - basic and diluted | $ | (0.19) | $ | (0.14) | $ | (0.08) | |||||
| Fiscal Year Ended December 31, | |||||||||||
| 2025 | 2024 | 2023 | |||||||||
| Restricted stock units | 1,156,335 | 667,931 | 1,047,501 | ||||||||
| Performance and market-based stock units | 1,262,795 | 947,452 | 1,625,882 | ||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 31, 2026 | Showing above |
| 2024 | Mar 14, 2025 | |
| 2023 | Feb 27, 2024 | |
| 2022 | Mar 10, 2023 | |
| 2021 | Mar 11, 2022 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.